Should everyone ageing with HIV take a statin?

Affiliations

¹ VA Connecticut Healthcare System, New Haven, CT, USA; Yale University West Haven, CT, USA. Electronic address: amy.justice2@va.gov.
² Vanderbilt University School of Medicine, Nashville, TN, USA.
³ University of Pennsylvania School of Medicine, Philadelphia, PA, USA.

Comment

Amy Justice et al. Lancet HIV. 2015 Feb.

. 2015 Feb;2(2):e36-7.

doi: 10.1016/S2352-3018(14)00062-9. Epub 2015 Jan 9.

¹ VA Connecticut Healthcare System, New Haven, CT, USA; Yale University West Haven, CT, USA. Electronic address: amy.justice2@va.gov.
² Vanderbilt University School of Medicine, Nashville, TN, USA.
³ University of Pennsylvania School of Medicine, Philadelphia, PA, USA.

No abstract available

Comment on

Effects of statin therapy on coronary artery plaque volume and high-risk plaque morphology in HIV-infected patients with subclinical atherosclerosis: a randomised, double-blind, placebo-controlled trial.
Lo J, Lu MT, Ihenachor EJ, Wei J, Looby SE, Fitch KV, Oh J, Zimmerman CO, Hwang J, Abbara S, Plutzky J, Robbins G, Tawakol A, Hoffmann U, Grinspoon SK. Lo J, et al. Lancet HIV. 2015 Feb;2(2):e52-63. doi: 10.1016/S2352-3018(14)00032-0. Epub 2015 Jan 9. Lancet HIV. 2015. PMID: 26424461 Free PMC article. Clinical Trial.